Search

153 Result(s)
Sort by

COVID-19 Boehringer Ingelheim Clinical Trials

COVID-19 Boehringer Ingelheim Clinical Trials

We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
COVID-19 Volunteering in the U.S.

COVID-19 Volunteering in the U.S.

BI employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
Green Chemistry

Green Chemistry

Green Chemistry is critical for us as it balances the long-term sustainability of business, society, and the environment. Click here to learn more.
Obesity osteoarthritis in pets a blind spot

Obesity osteoarthritis in pets a blind spot

Body weight is just one indicator among many when it comes to a pet’s health status, but there are some diseases associated with it. Learn more here.
Biberach

Biberach

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Biberach site.
COVID-19 In Colombia we support integrally

COVID-19 In Colombia we support integrally

At Boehringer Ingelheim Colombia, we are caring for those in the most vulnerable situations during COVID-19. Click here to learn more about our work.
Women in STEM 2022

Women in STEM 2022

Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM. Click here to find out more.
Circular economy towards the future

Circular economy towards the future

Boehringer Ingelheim uses eco-design to shape and develop animal health products with an improved environmental profile. Click here to read more.
Our-position

Our-position

12 years ago, several leading German companies including Boehringer Ingelheim came together to launch Afrika Kommt! Learn more about it here.
Transboundary and emerging diseases

Transboundary and emerging diseases

We fight TEDs through cutting-edge technologies. Click here to find out how our colleagues in Global Innovation and VPH prepare for outbreaks.
BI Access to Healthcare Strategy_Availability

BI Access to Healthcare Strategy_Availability

Through our Access to Healthcare Strategy, we want to ensure that our compounds are readily and responsibly available. Learn more about our work here.
Duluth

Duluth

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Duluth site.
The METAmorphosis

The METAmorphosis

At Boehringer Ingelheim’s META offices in the Middle East, Turkey and Africa all offices in the region are already free of single-use plastic. Learn more.
Resizing our Carbon Footprint

Resizing our Carbon Footprint

The ecological balance of the world is at a tipping point. Thus, we step up the initiative “Carbon Footprint”. Click here to find out more information.
Sant Cugat del Vallès

Sant Cugat del Vallès

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Shanghai site.
Stroke, Don’t Stay at Home

Stroke, Don’t Stay at Home

During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
3 scopes for sustainability Saint Vulbas France

3 scopes for sustainability Saint Vulbas France

Click here to find out how Boehringer Ingelheim is working to improve the sustainability and biodiversity of the research site at Saint-Vulbas in France.
Yamagata

Yamagata

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Yamagata site.
Our Employees

Our Employees

We offer our employees demanding and challenging tasks. Boehringer Ingelheim needs employees who innovate. Learn more about our employees here.